Biopharmaceutical

Why Cortexyme Shares Are Plunging 70% After Hours

ChemoCentryx Stock Needs To Hold At Support Or It May Slide Lower

Cannsun Medhel Expands Board, Names New Head Of Women's Health Division

ChemoCentryx Stock Needs To Hold At Support Or It May Slide Lower

Cannsun Medhel Expands Board, Names New Head Of Women's Health Division

PhaseBio's IPO: What You Need To Know

Why Raymond James Is Bullish On Deciphera, Dova Pharmaceuticals

PhaseBio's IPO: What You Need To Know

Why Raymond James Is Bullish On Deciphera, Dova Pharmaceuticals

Adamis Pharma's Monday Morning Rally: What You Need To Know

Verastem Shares Hit Highest Level Since 2015 On Duvelisib Data

Biopharmaceutical Recent News

Emergent Biosolutions' Stock Run Can't Continue Forever, Wells Fargo Says In Downgrade

HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold

What's The Thesis On ProQR Now, After Promising Phase 1 Data?

Alnylam Pharmaceutical Surges After Rare Disease Drug Meets Key Endpoints

INC Research Confirms Completion Of Merger With InVentiv Health

Here's Why Shares Of Intercept Jumped Nearly 10% On Friday

AEterna Zentraris Surged 17%: Here Is What You Need To Know

Here's Why Shares Of Onco Genex Pharma Are Plunging

Acorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development

Shares Of Auris Medical Continue Surging On No News

Conatus Pharmaceuticals Surges 25% Following Positive Results In Phase 2 Study

Shares Of Otonomy Plunge Following Public Offering Of Stock

Why Shares Of Chimerix Were Halted

Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Trading Pro Discusses The 'Honey Badger' Stock He Just Bought